Literature DB >> 9654829

Thioridazine in the management of cancer-related sweating.

J Cowap, J Hardy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9654829

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN： 0885-3924            Impact factor:   3.612


× No keyword cloud information.
  4 in total

Review 1.  Statement on malignant mesothelioma in the United Kingdom.

Authors: 
Journal:  Thorax       Date:  2001-04       Impact factor: 9.139

2.  Gabapentin in the treatment of severe sweating experienced by advanced cancer patients.

Authors:  Giampiero Porzio; Federica Aielli; Lucilla Verna; Claudio Porto; Paolo Aloisi; Katia Cannita; Enrico Ricevuto; Paolo Marchetti; Corrado Ficorella
Journal:  Support Care Cancer       Date:  2006-01-10       Impact factor: 3.603

3.  Thioridazine inhibits angiogenesis and tumor growth by targeting the VEGFR-2/PI3K/mTOR pathway in ovarian cancer xenografts.

Authors:  Mi Sun Park; Seung Myung Dong; Boh-Ram Kim; Seung Hee Seo; Sokbom Kang; Eun-Ju Lee; Seung-Hoon Lee; Seung Bae Rho
Journal:  Oncotarget       Date:  2014-07-15

Review 4.  Repurposing Antipsychotics for Cancer Treatment.

Authors:  Nikolaos Vlachos; Marios Lampros; Spyridon Voulgaris; George A Alexiou
Journal:  Biomedicines       Date:  2021-11-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.